Get the Weekly Intelligence Brief — top committee picks every Sunday.

CNO vs SF

CNO Financial Group vs Stifel — AI-powered side-by-side comparison
CNO
CNO Financial Group
54
Watch
VS
SF
Stifel
67
Buy
MetricCNOSF
AI Score 54 67
Price $54.27 $79.72
P/E Ratio 18.26× 8.89×
ROE 8.7% 11.4%
Revenue Growth YoY
Gross Margin 43.4% 84.9%
Debt / Equity 1.76× 0.14×
Dividend Yield 1.3% 1.8%
RSI (14) 50.9 36.0
Beta 0.817 0.992
Expected Upside +3.7%

AI Committee View

Current Innellis committee reasoning for CNO versus SF.
SF leads by 13 points.

SF scores 67/100 (Buy) versus CNO at 54/100 (Watch).

CNO Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 1.54) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • Debt-to-equity of 1.54 adds balance-sheet risk to the value case — Value
  • EPS declining -12.8% YoY despite any revenue growth — Growth
  • MACD histogram negative -- bearish momentum — Technical
SF Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CNO Full Analysis SF Full Analysis